A U.S. drug manufacturer is working on expanding their global
marketing by approaching both regulated and non-regulated markets.
The manufacturer is also thinking of expanding manufacturing sites
which may include new sites outside of the United States. The
manufacturer expects that their drug product (DP) will be a
suitable therapy for the global population, and this will require
global supply chain and distribution. When planning global
manufacturing strategies, which of the following would be the most
feasible strategic approach?
Group of answer choices
A) The manufacturing should be centralized in one country.
B) The manufacturing and supply chain should be based upon the
global specific zones to create supply for each zone.
C) There could be a possibility of a multi-domestic supply chain
with a manufacturing facility in each country.
A U.S. drug manufacturer is working on expanding their global marketing by approaching both regulated and non-regulated
-
- Site Admin
- Posts: 899603
- Joined: Mon Aug 02, 2021 8:13 am